Patents Assigned to The University of Ottawa
  • Publication number: 20210001007
    Abstract: Provided herein are scaffold biomaterials comprising a decellularised plant or fungal tissue from which cellular materials and nucleic acids of the tissue are removed, the decellularised plant or fungal tissue comprising a cellulose- or chitin-based 3-dimensional porous structure. Methods for preparing such scaffold biomaterials, as well as uses thereof as an implantable scaffold for supporting animal cell growth, for promoting tissue regeneration, for promoting angiogenesis, for a tissue replacement procedure, and/or as a structural implant for cosmetic surgery are also provided. Therapeutic treatment and/or cosmetic methods employing such scaffolds are additionally described.
    Type: Application
    Filed: April 14, 2020
    Publication date: January 7, 2021
    Applicant: University of Ottawa
    Inventors: Andrew Edward PELLING, Charles Michel CUERRIER, Daniel J. MODULEVSKY, Ryan Joseph HICKEY
  • Patent number: 10882802
    Abstract: The present application provides a hydrodefluorodimerization process, which is useful in the synthesis of, for example, fluoroolefins that can be used as refrigerants, blowers and the like. The process is an “early-stage fluorination” process, wherein precursors containing fluorine are assembled into the desired product using a zerovalent nickel catalyst. Also provided is a liquid composition comprising one or more fluoroolefin produced by this catalytic process.
    Type: Grant
    Filed: June 2, 2020
    Date of Patent: January 5, 2021
    Assignee: UNIVERSITY OF OTTAWA
    Inventors: Ralph Thomas Baker, Alexandre James Sicard
  • Publication number: 20200412447
    Abstract: An optical performance monitor comprises a first stage configured to receive a multiplexed optical signal. The first stage is tunable over a period. The first stage periodically filters the multiplexed optical signal over an optical channel to produce a fine filtered optical signal. A second stage is coupled to the first stage and has a second-stage transfer function. The second stage receives the fine filtered optical signal and produces one or a plurality of interfered optical signal pairs. A third stage is coupled to the second stage and has a third-stage transfer function. The third stage receives the optical signal pairs and demultiplexes the optical signal pairs to produce a plurality of demultiplexed optical signals. The combination of the second-stage transfer function and the third-stage transfer function is flatter over the optical channel than the third-stage transfer function.
    Type: Application
    Filed: June 1, 2020
    Publication date: December 31, 2020
    Applicants: Huawei Technologies Canada Co., Ltd., The University of Ottawa
    Inventors: Mohammad Mehdi MANSOURI RAD, Patrick DUMAIS, Trevor James HALL, Mehedi HASAN
  • Patent number: 10851372
    Abstract: A method for preparing exosomes or exosome-like vesicles packaged with a nucleic acid of interest is provided. In certain embodiments, the method may comprise: introducing into an exosome-producing cell a nucleic acid construct comprising the nucleic acid sequence of interest incorporated in a pre-miR-451 structural mimic, and allowing the cell to produce exosomes. Nucleic acid constructs, compositions, and uses thereof are also provided.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: December 1, 2020
    Assignee: University of Ottawa
    Inventors: Derrick Gibbings, James Andrew Taylor
  • Publication number: 20200354351
    Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.
    Type: Application
    Filed: May 18, 2020
    Publication date: November 12, 2020
    Applicants: Ottawa Hospital Research Institute, University of Ottawa
    Inventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
  • Publication number: 20200325593
    Abstract: Nanopore arrays are fabricated by controlled breakdown in solid-state membranes integrated within polydimethylsiloxane (PDMS) microfluidic devices. This technique enables the scalable production of independently addressable nanopores. By confining the electric field within the microfluidic architecture, nanopore fabrication is precisely localized and electrical noise is significantly reduced during sensing.
    Type: Application
    Filed: June 22, 2020
    Publication date: October 15, 2020
    Applicant: THE UNIVERSITY OF OTTAWA
    Inventors: Vincent TABARD-COSSA, Michel GODIN, Radin TAHVILDARI, Eric BEAMISH
  • Patent number: 10774021
    Abstract: The present application provides a hydrodefluorination process for the preparation of hydrofluoroalkenes by catalyzed substitution of one or more F atoms of a C2-C30 fluoroalkene, or a C2-C10 fluoroalkene, with one or more H atoms using a hydride source, such as a silane, and copper catalyst. During this process at least one C—F bond in the fluoroakene is converted to a C—H bond. The process is useful in the manufacture of hydrofluoroalkenes, such as hydrofluoroalkenes employed as, for example, refrigerants and blowers. Also provided are precatalyst compositions for performing the process, and formulations manufactured from hydrofluoroalkenes produced using the process.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: September 15, 2020
    Assignee: University of Ottawa
    Inventors: Ralph Thomas Baker, Nicholas Orlando Andrella
  • Patent number: 10759683
    Abstract: Provided herein are methods for removing mercury contaminant from an aqueous solution, the methods including: providing an aqueous solution, the aqueous solution being contaminated with at least trace amounts of an oxidized mercury species; culturing a photoheterotrophic or fermentative heterotrophic bacteria in the aqueous solution under anaerobic conditions in which the bacteria reduce the oxidized mercury species to elemental mercury (Hg0), wherein the bacteria comprises one or more bacteria of the order Clostridiales; and removing the elemental mercury from the aqueous solution. Also provided are bioreactors for removing mercury contaminant from an aqueous solution, as well as uses of photoheterotrophic or fermentative heterotrophic bacteria, wherein the bacteria comprises one or more bacteria of the order Clostridiales, for removing mercury contaminant from an aqueous solution.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: September 1, 2020
    Assignee: University of Ottawa
    Inventors: Alexandre Poulain, Daniel Grégoire
  • Patent number: 10753009
    Abstract: A method for fabricating a nanopore at a particular location in a membrane includes controlling a dielectric strength of the membrane at a particular location on the membrane while applying one of an electric potential or an electric current to the membrane, monitoring an electrical property across the membrane while one of the electric potential or the electric current is being applied across the membrane, detecting an abrupt change in the electrical property across the membrane while one of the electric potential or the electric current is being applied across the membrane; and removing the electric potential or the electric current from the membrane in response to detecting the abrupt change in the electrical property.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: August 25, 2020
    Assignee: THE UNIVERSITY OF OTTAWA
    Inventors: Jose Bustamante, Kyle Briggs, Vincent Tabard-Cossa
  • Patent number: 10721954
    Abstract: Bacterial strains are provided that can be isolated from the microflora of lowbush blueberry (Vaccinium angustifolium), and that are capable of increasing the antioxidant content of their growth medium. The bacteria can be used, for example, to increase the antioxidant content of various foodstuffs, as probiotics or as additives to animal feed. Antioxidant-enriched compositions produced by fermentation processes utilizing the bacteria are also provided. The antioxidant-enriched compositions can be used in the preparation of cosmetics and nutritional supplements. The antioxidant-enriched compositions also have therapeutic applications.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: July 28, 2020
    Assignee: University of Ottawa
    Inventors: Chantal Matar, Luc J. Martin
  • Patent number: 10703695
    Abstract: The present application provides a hydrodefluorodimerization process, which is useful in the synthesis of, for example, fluoroölefins that can be used as refrigerants, blowers and the like. The process is an “early-stage fluorination” process, wherein precursors containing fluorine are assembled into the desired product using a zerovalent nickel catalyst. Also provided is a liquid composition comprising one or more fluoroölefin produced by this catalytic process.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: July 7, 2020
    Assignee: University of Ottawa
    Inventors: Ralph Thomas Baker, Alexandre James Sicard
  • Patent number: 10677652
    Abstract: A method and apparatus is provided for implementing a parametric down-conversion (PDC)-based calibration comprising calibrating a measuring instrument; disposing a pinhole at a position of a light-emitting sample for which the measuring instrument needs to be calibrated; irradiating a nonlinear crystal with a light source; setting the nonlinear crystal by ensuring a phase-matching wavelength of the nonlinear crystal is set at one boundary of a desired bandwidth; acquiring one or more PDC spectrums by the measuring instrument; obtaining peak values and their corresponding wavelengths from each acquired spectrum; and obtaining a response function based on the peak values and corresponding wavelengths.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: June 9, 2020
    Assignees: University of Ottawa, Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V., Friedrich-Alexander-Universitaet Erlangen-Nuernberg
    Inventors: Samuel Lemieux, Mathieu Manceau, Robert W. Boyd, Gerd Leuchs, Maria V. Chekhova
  • Patent number: 10654839
    Abstract: Provided are compounds of Formula (II) that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.
    Type: Grant
    Filed: January 26, 2016
    Date of Patent: May 19, 2020
    Assignees: Ottawa Hospital Research Institute, University of Ottawa
    Inventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
  • Publication number: 20200144433
    Abstract: A photovoltaic device comprises at least two sub-cells, at least one connecting element electrically connecting adjacent sub-cells to one another, each sub-cell comprising: at least one segment; and at least one connecting element electrically connecting adjacent segments to one another in the event that a sub-cell has more than one segment; each one of the sub-cells having a unique bandgap and being arranged such that bandgaps of the sub-cells are in descending order with respect to a light incident surface of the photovoltaic device, each sub-cell being designed such that all segments of the photovoltaic device produce approximately the same current.
    Type: Application
    Filed: June 22, 2018
    Publication date: May 7, 2020
    Applicant: UNIVERSITY OF OTTAWA
    Inventors: Christopher E. VALDIVIA, Karin HINZER
  • Publication number: 20200091677
    Abstract: An optical power transfer device with an embedded active cooling chip is disclosed. The device includes a cooling chip made of a semiconductor material, and a first subassembly and a second subassembly mounted on the cooling chip. The cooling chip comprises at least one metallization layer on a portion of a first surface of the cooling chip, at least one inlet through a second surface of the cooling chip, wherein the second surface is opposite to the first surface, at least one outlet through the second surface and one or more micro-channels extending between and fluidly coupled to the at least one inlet and the at least one outlet. A cooling fluid flows through the one or more micro-channels. The first subassembly is mounted on the at least one metallization layer and comprises a laser. The second subassembly comprises a phototransducer configured to receive a laser beam from the laser.
    Type: Application
    Filed: September 14, 2018
    Publication date: March 19, 2020
    Applicants: Toyota Motor Engineering & Manufacturing North America, Inc., University of Ottawa, Broadcom Inc.
    Inventors: Ercan M. Dede, Christopher Valdivia, Matthew Wilkins, Karin Hinzer, Philippe-Olivier Provost, Denis Masson, Simon Fafard
  • Patent number: 10591485
    Abstract: There are provided dicysteine peptide tags for use with dimaleimide fluorescent labelling agents for the labelling and detection of specific protein targets. Peptide tags comprising the amino acid sequence set forth in SEQ ID NO: 2 are described.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: March 17, 2020
    Assignee: UNIVERSITY OF OTTAWA
    Inventors: Jeffrey Keillor, Miroslava Strmiskova
  • Patent number: 10526218
    Abstract: Aspects of the present disclosure are directed to the flow of analytes, particles or other materials. As consistent with one or more embodiments described herein, an apparatus includes a membrane having one or more pores in a membrane. First and second electrodes facilitate electrophoretic flow of analytes through the pore, and a third electrode controls movement of the particles in the pore by modulating the shape of an electric double layer adjacent sidewalls of pore. This modulation controls the strength of an electroosmotic field that opposes the electrophoretic flow of the analytes via the pore.
    Type: Grant
    Filed: October 1, 2013
    Date of Patent: January 7, 2020
    Assignees: The Board of Trustees of the Leland Stanford Junior University, The University of Ottawa
    Inventors: Kee-Hyun Paik, Yang Liu, Vincent Tabard-Cossa, Robert W. Dutton
  • Publication number: 20190389814
    Abstract: There are provided Tissue Transglutaminase (TG2) inhibitor compounds, and compositions and methods of use thereof for the prevention or treatment of a cancer.
    Type: Application
    Filed: April 13, 2017
    Publication date: December 26, 2019
    Applicants: UNIVERSITY OF OTTAWA, UNIVERSITY OF MARYLAND, BALTIMORE, UNIVERSITY OF ROCHESTER
    Inventors: Jeffrey W. KEILLOR, Abdullah AKBAR, Richard L. ECKERT, Matthew FISHER, Gail V. W. JOHNSON
  • Patent number: 10401479
    Abstract: A method and system is described for using radar to provide non-contact detection of human breathing at a distance. Radar data is processed to remove clutter and enable detection of a breathing signal. The breathing signal can be used to determine breathing rate or posture of the target. Static obstructions can be removed from the radar data to identify target breathing signal. The system and method can be applicable to emergency response, home or institutional monitoring applications and for detection of medical conditions.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: September 3, 2019
    Assignee: University of Ottawa
    Inventors: Mohamed Mabrouk, Izmail Batkin, Sreeraman Rajan, Miodrag Bolic, Voicu Groza, Hilmi Dajani
  • Publication number: 20190194096
    Abstract: The present application provides a hydrodefluorination process for the preparation of hydrofluoroalkenes by catalyzed substitution of one or more F atoms of a C2-C30 fluoroalkene, or a C2-C10 fluoroalkene, with one or more H atoms using a hydride source, such as a silane, and copper catalyst. During this process at least one C—F bond in the fluoroakene is converted to a C—H bond. The process is useful in the manufacture of hydrofluoroalkenes, such as hydrofluoroalkenes employed as, for example, refrigerants and blowers. Also provided are precatalyst compositions for performing the process, and formulations manufactured from hydrofluoroalkenes produced using the process.
    Type: Application
    Filed: August 30, 2017
    Publication date: June 27, 2019
    Applicant: UNIVERSITY OF OTTAWA
    Inventors: Ralph Thomas BAKER, Nicholas Orlando ANDRELLA